Basil Rigas

Stony Brook University Hospital — United States

Medicine · Health Sciences

56h-index11.0kcitations265works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(92), Eicosanoids and Hypertension Pharmacology(41), Estrogen and related hormone effects(31), Cancer, Stress, Anesthesia, and Immune Response(27), Ocular Surface and Contact Lens(24)

Publications265 total

Comparative Performance of Artificial Tear Drops Assessed with Objective Non-Invasive Imaging
Clinical ophthalmology·2025Open Access
Monitoring the Evolution of Dry Eye Disease in Rabbits with Advanced Ocular Keratography: Implications for Translational Studies
Current Eye Research·2025
Pharmacokinetics and biodistribution of topical phosphosulindac and its metabolites in mice and a mouse model for chemotherapy-induced peripheral neuropathy
Medical Research Archives·2025Open Access
Ex Vivo Drug Evaluation Using Human Ocular Cells: A Contribution to Drug Discovery
2024Open Access
The Evolving Landscape of Dry Eye Disease Therapies
JOJ Ophthalmology·2024Open Access
Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice
Frontiers in Neuroscience·2024· 2 citedOpen Access
Animal models of Dry Eye Disease: Application to Drug Discovery
Medical Research Archives·2024Open Access
The Antiangiogenic Effect and Ocular Pharmacology of Novel Modified Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Oxygen-Induced Retinopathy
Journal of Ocular Pharmacology and Therapeutics·2023· 3 citedOpen Access
Data from Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice
2023Open Access
Supplementary Figure 1 from Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
2023Open Access
Supplemental figures 1-8 from Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice
2023Open Access
Data from Aerosol Administration of Phospho-Sulindac Inhibits Lung Tumorigenesis
2023Open Access
Data from Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
2023Open Access
Supplementary Figures 1 - 10, Tables 1 - 2 from Aerosol Administration of Phospho-Sulindac Inhibits Lung Tumorigenesis
2023Open Access
Supplementary Figures 1 - 10, Tables 1 - 2 from Aerosol Administration of Phospho-Sulindac Inhibits Lung Tumorigenesis
2023Open Access
Data from Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice
2023Open Access
Data from Aerosol Administration of Phospho-Sulindac Inhibits Lung Tumorigenesis
2023Open Access
Supplemental figures 1-8 from Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice
2023Open Access
Supplementary Figure 1 from Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
2023Open Access
Data from Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Khosrow Kashfi(11), Steven J. Shiff(10), Liang Qiao(6), Jennie L. Williams(6), Rashid Hanif(5), Markos I. Koutsos(4), Paul Wong(4), Thomas A. Godwin(4), Miriam Rafailovich(4), Piero Del Soldato(4), Jianjun Gao(4), Levy Kopelovich(4), Nengtai Ouyang(4), Zhiquan Zhang(3), Frank Traganos(3), Anastasios Pittas(2), Lisa Staiano‐Coico(2), Thomas A. Caputo(2), Steven J. Shiff(2), I S Goldman(2)